We’re improving your experience!

×

Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.

Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.

Stay tuned for these updates, and thank you for being part of our community!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04216953
Title MEK Inhibitor and a PDL1 Inhibitor Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma (COTESARC)
Acronym COTESARC
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Centre Leon Berard
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Institut de Cancérologie de l'Ouest Angers 49055 France Details
Centre Oscar Lambret Lille 59020 France Details
Centre Léon Bérard Lyon 69008 France Details
Hôpital de la Timone Marseille 13385 France Details
Institut Curie Paris France Details
Institut Gustave Roussy Villejuif 94800 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field